Primary Care/Hospitalist
RSSArticles
-
Suspected Sexual Transmission of Zika Virus Reported from Female to Male
It’s time to raise the index of suspicion when it comes to the Zika virus: The New York City Department of Health and Mental Hygiene recently reported a suspected female-to-male sexual transmission of Zika virus.
-
Pregnancy Prevention Toolkit Helps Prevent Spread of Zika Virus
All healthcare providers, especially family planning professionals, should integrate Zika virus prevention into their standard clinical care, according to a new health provider toolkit from the CDC and Office of Population Affairs.
-
Clinical Briefs
In this section:
-
Sofosbuvir and Velpatasvir Tablets (Epclusa)
Sofosbuvir and velpatasvir tablets are indicated for the treatment of adult patients with chronic HCV genotype 1, 2, 3, 4, 5, or 6 infections.
-
Reduced Cardiac Index Is Not Correlated with Renal Function in Heart Failure Patients
In a retrospective analysis of patients with acute decompensated heart failure who received a pulmonary artery catheter, there was no significant correlation between cardiac index and markers of renal function, contradicting the importance of cardiac output in renal dysfunction among patients with heart failure.
-
Should Lipid Measurements Be Obtained in the Fasting or Nonfasting State?
When attempting to determine whether fasting or nonfasting lipid measurements are most appropriate in an individual patient, it is important to first think carefully about the clinical scenario and consider what question the results answer.
-
Can a Brain Condition Affect the Heart?
A large, prospective cohort study in women with more than two decades of follow-up indicated a consistent link between migraine and cardiovascular disease events, including cardiovascular mortality.
-
Cerebral Microbleeds: Risk Factor for Symptomatic Intracerebral Hemorrhage
Cerebral microbleeds (CMBs), as visualized on gradient-echo or susceptibility-weighted MRI, are considered markers of bleeding-prone cerebral microvessels and constitute a significant and independent predictor of future intracerebral hemorrhage. -
Buprenorphine Implant for Subdermal Administration (Probuphine)
The FDA has approved the first buprenorphine implant for the treatment of opioid dependence. Buprenorphine is a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor. Buprenorphine was previously approved as oral and sublingual tablets. The implant is marketed as Probuphine.
-
Human Adenovirus B7: Severe Infection
ABSTRACT & COMMENTARY: Patients with HAdV-B7 were more likely to be adults and to have longer hospital stays.